Viva Biotech Holdings
HKEX:1873.HK
0.61 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Revenue
| 2,155.578 | 2,379.631 | 2,104.083 | 696.958 | 323.057 | 210.033 | 148.245 | 96.492 |
Cost of Revenue
| 1,417.146 | 1,563.952 | 1,453.102 | 392.092 | 167.184 | 104.576 | 62.056 | 42.349 |
Gross Profit
| 738.432 | 815.679 | 650.981 | 304.866 | 155.873 | 105.457 | 86.189 | 54.143 |
Gross Profit Ratio
| 0.343 | 0.343 | 0.309 | 0.437 | 0.482 | 0.502 | 0.581 | 0.561 |
Reseach & Development Expenses
| 127.967 | 135.835 | 92.382 | 66.041 | 44.954 | 25.251 | 17.253 | 16.794 |
General & Administrative Expenses
| 277.109 | 273.649 | 225.711 | 110.163 | 51.215 | 25.576 | 15.228 | 12.827 |
Selling & Marketing Expenses
| 132.547 | 130.804 | 93.974 | 13.095 | 3.571 | 3.925 | 2.017 | 1.392 |
SG&A
| 409.656 | 410.495 | 321.698 | 123.258 | 54.786 | 29.614 | 17.245 | 14.219 |
Other Expenses
| 164.272 | -1.442 | 133.251 | -582.638 | -34.207 | 0 | -5.738 | 0.333 |
Operating Expenses
| 482.307 | 1,111.776 | 146.747 | 615.652 | 112.227 | 0.1 | 28.76 | 25.069 |
Operating Income
| 192.683 | 265.98 | 236.901 | 112.538 | 54.321 | 50.592 | 52.763 | 28.425 |
Operating Income Ratio
| 0.089 | 0.112 | 0.113 | 0.161 | 0.168 | 0.241 | 0.356 | 0.295 |
Total Other Income Expenses Net
| -248.636 | -725.145 | 110.8 | -468.748 | 226.604 | 55.269 | 34.048 | -0.005 |
Income Before Tax
| -55.953 | -459.165 | 347.701 | -356.21 | 280.925 | 105.861 | 86.811 | 28.42 |
Income Before Tax Ratio
| -0.026 | -0.193 | 0.165 | -0.511 | 0.87 | 0.504 | 0.586 | 0.295 |
Income Tax Expense
| 43.837 | 45.055 | 47.141 | 22.66 | 15.053 | 15.311 | 10.551 | 3.947 |
Net Income
| -116.113 | -528.475 | 287.546 | -386.88 | 265.872 | 90.55 | 76.26 | 24.473 |
Net Income Ratio
| -0.054 | -0.222 | 0.137 | -0.555 | 0.823 | 0.431 | 0.514 | 0.254 |
EPS
| -0.06 | -0.28 | 0.15 | -0.25 | 0.19 | 0.08 | 0.051 | 0.016 |
EPS Diluted
| -0.057 | -0.28 | 0.083 | -0.25 | 0.18 | 0.076 | 0.051 | 0.016 |
EBITDA
| 594.155 | 436.354 | 369.939 | 164.348 | 70.784 | 60.14 | 58.264 | 32.207 |
EBITDA Ratio
| 0.276 | 0.183 | 0.176 | 0.236 | 0.219 | 0.286 | 0.393 | 0.334 |